Related by context. Frequent words. (Click for all words.) 75 Company Nasdaq PRGO 75 Inc Therapeutic Competitors 74 Transcept Pharmaceuticals 74 NASDAQ CRXL 74 Connetics Corporation 73 MarketTelegraph.com 73 Barrier Therapeutics Inc. 73 Calls Purchased 73 EPIX Pharmaceuticals Inc. 73 China Aoxing Pharmaceutical 72 Inc. Nasdaq SEPR 72 Inc. Nasdaq IMGN 72 Q1 Loss Narrows 72 Novelos Therapeutics Inc. 72 Fibrocell Science Inc. 72 LYON France BUSINESS WIRE 71 MiddleBrook Pharmaceuticals Inc. 71 Q3 Loss Narrows 71 Q2 Loss Narrows 71 ENZN 71 Genaera Corporation 71 BPAX 71 Advancing Drugs 71 Idera Pharmaceuticals 71 Adeona Pharmaceuticals Inc. 71 Metabasis Therapeutics Inc. 71 Crucell NV Euronext 71 Presents Positive 70 NovaBay Pharmaceuticals Inc. 70 Report companiesandmarkets.com adds 70 Stock Downgraded 70 Alseres Pharmaceuticals Inc. 70 Bearish Pressure Building 70 PROFILE CO 70 Inc. NASDAQ MRNA 70 Nastech Pharmaceutical Company 70 Stock Upgraded 70 Company www.dowjones.com 70 Intellect Neurosciences Inc. 70 Q2 Loss Widens 70 ShamrockStocks.com Lucky Picks 70 ACADIA Pharmaceuticals 70 NYSE MYL 70 OPTR 69 ALIM 69 Completes Enrollment 69 AKRX 69 Options Trader Alert 69 Q4 Loss Widens 69 Q4 Loss Narrows 69 Palatin Technologies Inc. 69 Vicor Technologies 69 FastMoneyTalk.com 69 RegeneRx Biopharmaceuticals Inc. 69 Joins OTCQX 69 PYMX 69 BioSpecifics Technologies Corp. 69 Pluristem Therapeutics Inc. 69 Q3 Loss Widens 69 Cyclacel Pharmaceuticals Inc. 69 NasdaqCM 69 Iomai Corporation 69 AUXL 69 QLTI 69 HAYWARD Calif. BUSINESS WIRE 69 NASDAQ CYPB 69 SGMO 69 DVAX 68 Inc. NasdaqGM 68 VRUS 68 Axxess Pharma Inc. 68 Looks Bearish 68 Inc. NASDAQ SNTS 68 IMPAX Laboratories Inc. 68 Schedules Fiscal 68 AVANIR Pharmaceuticals 68 VIA Pharmaceuticals 68 Posts Large Volume 68 Interesting Options Volume 68 CADX 68 Skymark Research Initiates Independent 68 Hold Fourth Quarter 68 Synergy Pharmaceuticals 68 Healthnostics Inc. 68 CRXX 68 Nasdaq ALTH 68 Q2 Profit Surges 68 Altus Pharmaceuticals Inc. 68 Cerus Corporation 68 GAITHERSBURG Md. BUSINESS WIRE 68 Genelabs Technologies Inc. 68 submitted Biologics License 68 www.lannett.com 68 Q1 Loss Widens 68 Explore Strategic Alternatives 68 BOPH 68 LXRX 67 Regains Compliance With 67 Nasdaq REGN 67 OSIR 67 DayTradersDigest.com